{"ABHD12":"liver enzyme levels (alkaline phosphatase)","ABHD12":"systemic lupus erythematosus","ACTR5":"liver fibrosis in pediatric non-alcoholic fatty acid liver disease","ADNP":"prostate cancer","ADRA1D":"periodontitis (mean pal)","ADRA1D":"preeclampsia","ADRA1D":"igg glycosylation","ADRA1D":"age-related nuclear cataracts","ADRA1D":"microalbuminuria","ADRA1D":"facial morphology (factor 20)","ADRA1D":"diisocyanate-induced asthma","ADRA1D":"paneth cell defects in crohn's disease","ADRA1D":"mononucleosis","AHCY":"liver fibrosis severity in hiv/hepatitis c co-infection","ANGPT4":"social communication problems","ANGPT4":"cognitive performance","ANGPT4":"estradiol plasma levels (breast cancer)","ANGPT4":"3-hydroxypropylmercapturic acid levels in smokers","ANGPT4":"3-hydroxy-1-methylpropylmercapturic acid levels in smokers","ANGPT4":"posterior cortical atrophy and alzheimer's disease","ANGPT4":"daytime sleep phenotypes","ANKRD60":"height","AP5S1":"heart rate","AP5S1":"resting heart rate","AP5S1":"photic sneeze reflex","AP5S1":"hepcidin levels","AP5S1":"heart rate variability traits (sdnn)","AP5S1":"heart rate variability traits (rmssd)","ARFGEF2":"anger","ARHGAP40":"schizophrenia","ATRN":"height","ATRN":"attention deficit hyperactivity disorder","ATRN":"freckling","ATRN":"protein c levels","ATRN":"cholesterol, total","ATRN":"d-dimer levels","ATRN":"anticoagulant levels","ATRN":"hemostatic factors and hematological phenotypes","ATRN":"prothrombin time","ATRN":"ulcerative colitis","ATRN":"spine bone size","ATRN":"migraine - clinic-based","ATRN":"amyotrophic lateral sclerosis (sporadic)","ATRN":"obesity-related traits","ATRN":"infant length","ATRN":"waist-to-hip ratio adjusted for body mass index","ATRN":"developmental dysplasia of the hip","ATRN":"venous thromboembolism","ATRN":"factor vii levels","ATRN":"triglycerides","ATRN":"thrombosis","ATRN":"qrs complex (cornell)","ATRN":"congenital left-sided heart lesions","ATRN":"melanoma","ATRN":"diisocyanate-induced asthma","ATRN":"response to paliperidone in schizophrenia (panss score)","ATRN":"response to paliperidone in schizophrenia (multivariate)","ATRN":"joint mobility (beighton score)","ATRN":"hip circumference adjusted for bmi","ATRN":"qrs interval (sulfonylurea treatment interaction)","ATRN":"hip circumference","ATRN":"total cholesterol levels","ATRN":"waist-to-hip ratio adjusted for bmi in active individuals","ATRN":"blood protein levels","ATRN":"waist-to-hip ratio adjusted for bmi (joint analysis for main effect and physical activity interaction)","ATRN":"reticulocyte fraction of red cells","ATRN":"high light scatter reticulocyte count","ATRN":"reticulocyte count","ATRN":"breast cancer","ATRN":"coronary artery disease","ATRN":"lobe attachment (rater-scored or self-reported)","ATRN":"neuroticism","BCAS1":"bipolar disorder and schizophrenia","BCAS1":"resting heart rate","BCAS1":"venous thromboembolism adjusted for sickle cell variant rs77121243-t","BCAS1":"red cell distribution width","BCAS1":"breast cancer","BCAS4":"breast cancer","BCL2L1":"subcortical brain region volumes","BCL2L1":"oppositional defiant disorder dimensions in attention-deficit hyperactivity disorder","BCL2L1":"plateletcrit","BCL2L1":"platelet count","BCL2L1":"putamen volume","BMP2":"obesity-related traits","BMP7":"oppositional defiant disorder dimensions in attention-deficit hyperactivity disorder","BMP7":"facial morphology (factor 5, width of mouth relative to central midface)","BMP7":"monobrow","BMP7":"nose size","BMP7":"reticulocyte fraction of red cells","BMP7":"high light scatter reticulocyte count","BMP7":"high light scatter reticulocyte percentage of red cells","BMP7":"reticulocyte count","BPI":"bipolar disorder and schizophrenia","BPI":"hepcidin levels","BPI":"cerebrospinal fluid biomarker levels","BPIFA2":"smooth-surface caries","C20orf27":"survival in colon cancer","C20orf27":"mean corpuscular volume","C20orf96":"response to tocilizumab in rheumatoid arthritis","C20orf96":"white matter integrity","C20orf194":"ulcerative colitis","C20orf194":"ifn-related cytopenia","C20orf194":"attention deficit hyperactivity disorder (combined symptoms)","C20orf194":"attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms)","C20orf194":"hair color","C20orf194":"smooth-surface caries","C20orf194":"height","C20orf194":"breast cancer","C20orf194":"type 1 diabetes nephropathy","C20orf194":"igg glycosylation","C20orf194":"inflammatory bowel disease","C20orf194":"type 2 diabetes","C20orf194":"stearic acid (18:0) levels","C20orf194":"dysphagia","C20orf194":"cancer","C20orf194":"cancer (pleiotropy)","C20orf194":"loneliness","C20orf194":"subjective well-being","C20orf194":"age at first birth","C20orf194":"post bronchodilator fev1/fvc ratio","C20orf194":"hip circumference adjusted for bmi","C20orf194":"iron status biomarkers (iron levels)","C20orf194":"iron status biomarkers (transferrin saturation)","C20orf194":"monocyte count","C20orf194":"white blood cell count (basophil)","C20orf194":"basophil percentage of white cells","C20orf194":"immature fraction of reticulocytes","C20orf194":"lymphocyte counts","C20orf194":"lymphocyte percentage of white cells","C20orf194":"monocyte percentage of white cells","C20orf194":"basophil percentage of granulocytes","C20orf194":"granulocyte percentage of myeloid white cells","C20orf194":"mean corpuscular hemoglobin","C20orf194":"red blood cell count","C20orf194":"red cell distribution width","C20orf194":"high light scatter reticulocyte count","C20orf194":"high light scatter reticulocyte percentage of red cells","C20orf194":"mean corpuscular volume","C20orf194":"asthma","C20orf194":"birth weight","C20orf194":"rubella","C20orf196":"hippocampal atrophy","C20orf196":"information processing speed","C20orf196":"pulmonary function decline","C20orf196":"response to fenofibrate (adiponectin levels)","C20orf196":"height","C20orf196":"response to cytadine analogues (cytosine arabinoside)","C20orf196":"obesity-related traits","C20orf196":"emphysema imaging phenotypes","C20orf196":"warfarin maintenance dose","C20orf196":"verbal declarative memory","C20orf196":"systolic blood pressure","C20orf196":"advanced age-related macular degeneration","C20orf196":"positive affect","C20orf196":"facial morphology (factor 1, breadth of lateral portion of upper face)","C20orf196":"cardiovascular risk factors (age interaction)","C20orf196":"hemoglobin concentration","C20orf196":"prudent dietary pattern","C20orf196":"change in lvef in response to paclitaxel and trastuzumab in her2+ breast cancer","C20orf196":"breast cancer","C20orf203":"subjective well-being","C20orf203":"white blood cell count (basophil)","C20orf203":"basophil percentage of white cells","C20orf203":"basophil percentage of granulocytes","CABLES2":"colorectal cancer","CABLES2":"coronary artery calcified atherosclerotic plaque score in type 2 diabetes","CD40":"rheumatoid arthritis","CD40":"chronic hepatitis b infection","CDC25B":"bipolar disorder","CDC25B":"skin pigmentation","CDH4":"volumetric brain mri","CDH4":"cerebrospinal t-tau levels","CDH4":"sudden cardiac arrest","CDH4":"longevity","CDH4":"&beta;2-glycoprotein i (&beta;2-gpi) plasma levels","CDH4":"axial length","CDH4":"migraine - clinic-based","CDH4":"bipolar disorder (body mass index interaction)","CDH4":"autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)","CDH4":"trans fatty acid levels","CDH4":"cognitive decline rate in late mild cognitive impairment","CDH4":"educational attainment (years of education)","CDH4":"obstructive sleep apnea trait (average respiratory event duration)","CDH4":"night sleep phenotypes","CDH4":"multiple system atrophy","CDH4":"coronary artery calcified atherosclerotic plaque (130 hu threshold) in type 2 diabetes","CDH4":"obesity-related traits","CDK5RAP1":"hair color","CDS2":"male infertility","CDS2":"self-reported allergy","CDS2":"amyotrophic lateral sclerosis (sporadic)","CDS2":"tourette's syndrome or obsessive-compulsive disorder","CDS2":"sitting height ratio","CDS2":"asparaginase hypersensitivity in acute lymphoblastic leukemia","CDS2":"nonsyndromic cleft lip with cleft palate","CDS2":"interleukin-6 levels","CDS2":"eosinophil percentage of white cells","CDS2":"sum eosinophil basophil counts","CDS2":"allergic disease (asthma, hay fever or eczema)","CDS2":"lobe attachment (rater-scored or self-reported)","CDS2":"white matter microstructure in first episode schizophrenia (right anterior cingulate cortex)","CEP250":"height","CFAP61":"immune response to smallpox vaccine (il-6)","CFAP61":"white wine liking","CFAP61":"exploratory eye movement dysfunction in schizophrenia (total eye scanning length)","CFAP61":"stem cell growth factor beta levels","CHD6":"hippocampal atrophy","CHD6":"gastric adenocarcinoma (histologically verified)","CHD6":"verbal declarative memory","CHD6":"immature fraction of reticulocytes","CHD6":"reticulocyte fraction of red cells","CHD6":"high light scatter reticulocyte count","CHD6":"high light scatter reticulocyte percentage of red cells","CHD6":"reticulocyte count","CHGB":"hypertension","CHGB":"blood pressure","CHGB":"diastolic blood pressure","CHGB":"systolic blood pressure","CHGB":"response to antipsychotic therapy (extrapyramidal side effects)","CHGB":"inflammatory bowel disease","CHGB":"attention function in attention deficit hyperactive disorder","CHGB":"ulcerative colitis","CHGB":"crohn's disease","CHGB":"lymphocyte counts","CHGB":"lymphocyte percentage of white cells","CHGB":"platelet distribution width","CHGB":"coronary artery disease","CHRNA4":"nicotine dependence","CHRNA4":"emphysema imaging phenotypes","CHRNA4":"facial morphology (factor 17, height of vermillion upper lip)","CNBD2":"hip circumference adjusted for bmi","COMMD7":"type 2 diabetes","CRLS1":"lentiform nucleus volume","CRLS1":"type 1 diabetes nephropathy","CRLS1":"metabolite levels (mhpg)","CRLS1":"glucose homeostasis traits","CRLS1":"chronic kidney disease (severe chronic kidney disease vs normal kidney function) in type 1 diabetes","CSE1L":"non-response to citalopram or escitalopram and depression","CSE1L":"subjective well-being","CSE1L":"positive affect","CSE1L":"intelligence","CSE1L":"intelligence (multi-trait analysis)","CSNK2A1":"tonometry","CSNK2A1":"amyotrophic lateral sclerosis","CSNK2A1":"psoriasis","CSNK2A1":"response to treatment for acute lymphoblastic leukemia","CSNK2A1":"attention deficit hyperactivity disorder (time to onset)","CSNK2A1":"male infertility","CSNK2A1":"hemoglobin","CSNK2A1":"calcium levels","CSNK2A1":"attention deficit hyperactivity disorder","CSNK2A1":"bipolar disorder","CSNK2A1":"nephrotic syndrome (acquired)","CSNK2A1":"subcutaneous adipose tissue","CSNK2A1":"polycystic ovary syndrome","CSNK2A1":"molar-incisor hypomineralization","CSNK2A1":"osteoarthritis (hip)","CSNK2A1":"alcohol consumption","CSNK2A1":"narcolepsy with cataplexy","CSNK2A1":"body mass index in non-asthmatics","CSNK2A1":"qt interval","CSNK2A1":"self-reported allergy","CSNK2A1":"attention deficit hyperactivity disorder (combined symptoms)","CSNK2A1":"attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms)","CSNK2A1":"amyotrophic lateral sclerosis (sporadic)","CSNK2A1":"atrial fibrillation","CSNK2A1":"bipolar disorder (body mass index interaction)","CSNK2A1":"anger","CSNK2A1":"thyroid peroxidase antibody positivity","CSNK2A1":"systemic lupus erythematosus","CSNK2A1":"multiple sclerosis","CSNK2A1":"height","CSNK2A1":"bipolar disorder and schizophrenia","CSNK2A1":"atopic dermatitis","CSNK2A1":"igg glycosylation","CSNK2A1":"obesity","CSNK2A1":"obesity-related traits","CSNK2A1":"qt interval (drug interaction)","CSNK2A1":"tourette's syndrome or obsessive-compulsive disorder","CSNK2A1":"prostate cancer","CSNK2A1":"schizophrenia","CSNK2A1":"seasonality","CSNK2A1":"infant length","CSNK2A1":"sitting height ratio","CSNK2A1":"inflammatory bowel disease","CSNK2A1":"palmitic acid (16:0) levels","CSNK2A1":"asparaginase hypersensitivity in acute lymphoblastic leukemia","CSNK2A1":"urate levels in obese individuals","CSNK2A1":"hair morphology","CSNK2A1":"colorectal cancer (oestrogen-progestogen hormone therapy interaction)","CSNK2A1":"longitudinal change in brain amyloid plaque burden","CSNK2A1":"ulcerative colitis","CSNK2A1":"warfarin maintenance dose","CSNK2A1":"white matter hyperintensity burden","CSNK2A1":"glomerular filtration rate (creatinine)","CSNK2A1":"inflammatory skin disease","CSNK2A1":"colorectal cancer","CSNK2A1":"body mass index","CSNK2A1":"psoriasis vulgaris","CSNK2A1":"alzheimer disease and age of onset","CSNK2A1":"coronary artery aneurysm in kawasaki disease","CSNK2A1":"gut microbiota (beta diversity)","CSNK2A1":"gut microbiota (functional units)","CSNK2A1":"bipolar disorder or attention deficit hyperactivity disorder","CSNK2A1":"serum parathyroid hormone levels","CSNK2A1":"glomerular filtration rate","CSNK2A1":"bipolar disorder (age of onset <21) or attention deficit hyperactivity disorder","CSNK2A1":"educational attainment (years of education)","CSNK2A1":"modified stumvoll insulin sensitivity index (bmi interaction)","CSNK2A1":"non-response to citalopram or escitalopram and depression","CSNK2A1":"subjective well-being","CSNK2A1":"life satisfaction","CSNK2A1":"positive affect","CSNK2A1":"depression","CSNK2A1":"night sleep phenotypes","CSNK2A1":"post bronchodilator fev1","CSNK2A1":"post bronchodilator fev1/fvc ratio in copd","CSNK2A1":"type 2 diabetes (age of onset)","CSNK2A1":"facial morphology (factor 23)","CSNK2A1":"nonsyndromic cleft lip with cleft palate","CSNK2A1":"intelligence","CSNK2A1":"alanine aminotransferase (alt) levels after remission induction therapy in actute lymphoblastic leukemia (all)","CSNK2A1":"cerebrospinal fluid ab1-42 levels","CSNK2A1":"stem cell growth factor beta levels","CSNK2A1":"reading disability or specific language impairment (pleiotropy)","CSNK2A1":"multiple myeloma","CSNK2A1":"resting heart rate","CSNK2A1":"venous thromboembolism adjusted for sickle cell variant rs77121243-t","CSNK2A1":"waist-hip ratio","CSNK2A1":"waist circumference","CSNK2A1":"diastolic blood pressure","CSNK2A1":"interleukin-6 levels","CSNK2A1":"testicular germ cell tumor","CSNK2A1":"monocyte count","CSNK2A1":"immature fraction of reticulocytes","CSNK2A1":"vitamin d levels","CSNK2A1":"eosinophil percentage of white cells","CSNK2A1":"waist circumference adjusted for bmi (joint analysis main effects and smoking interaction)","CSNK2A1":"waist circumference adjusted for bmi in non-smokers","CSNK2A1":"bmi (adjusted for smoking behaviour)","CSNK2A1":"body mass index (joint analysis main effects and smoking interaction)","CSNK2A1":"lymphocyte counts","CSNK2A1":"monocyte percentage of white cells","CSNK2A1":"sum eosinophil basophil counts","CSNK2A1":"waist circumference adjusted for bmi (adjusted for smoking behaviour)","CSNK2A1":"bmi in non-smokers","CSNK2A1":"granulocyte percentage of myeloid white cells","CSNK2A1":"hematocrit","CSNK2A1":"mean corpuscular hemoglobin","CSNK2A1":"red blood cell count","CSNK2A1":"reticulocyte fraction of red cells","CSNK2A1":"red cell distribution width","CSNK2A1":"high light scatter reticulocyte count","CSNK2A1":"high light scatter reticulocyte percentage of red cells","CSNK2A1":"mean corpuscular volume","CSNK2A1":"reticulocyte count","CSNK2A1":"vitiligo","CSNK2A1":"breast cancer","CSNK2A1":"coronary artery disease","CSNK2A1":"colonoscopy-negative controls vs population controls","CSNK2A1":"nucleus accumbens volume in trauma-exposed individuals","CSNK2A1":"cognitive ability","CSNK2A1":"cognitive ability (multi-trait analysis)","CSNK2A1":"colorectal adenoma (advanced)","CSNK2A1":"urinary tract infection frequency","CSNK2A1":"rheumatic fever","CSNK2A1":"allergic disease (asthma, hay fever or eczema)","CSNK2A1":"anti-saccade response","CSNK2A1":"lobe attachment (rater-scored or self-reported)","CSNK2A1":"white matter microstructure in first episode schizophrenia (right anterior cingulate cortex)","CSNK2A1":"hepatitis b","CSNK2A1":"tuberculosis","CSNK2A1":"intelligence (multi-trait analysis)","CST1":"blood protein levels","CST3":"plasma cystastin c levels in acute coronary syndrome","CST3":"chronic kidney disease","CST3":"blood protein levels","CTNNBL1":"bone mineral density","CTNNBL1":"visceral adipose tissue adjusted for bmi","CTNNBL1":"cognitive decline rate in late mild cognitive impairment","DDX27":"intelligence (multi-trait analysis)","DEFB126":"mean platelet volume","DEFB126":"non-alcoholic fatty liver disease histology (other)","DEFB126":"mood disorder in prion disease","DEFB127":"thyroid-associated orbitopathy in graves' disease","DEFB127":"body mass index","DEFB127":"trail levels","DEFB128":"homeostasis model assessment of insulin resistance (dietary factor interaction)","DEFB128":"fasting insulin (dietary factor interaction)","DEFB128":"c-reactive protein (red blood cell fatty acid level interaction)","DEFB128":"alcoholic chronic pancreatitis","DEFB129":"age of smoking initiation","DEFB129":"obesity-related traits","DEFB129":"vitamin d levels","DEFB129":"gout","DEFB132":"obesity-related traits","DEFB132":"3-hydroxy-1-methylpropylmercapturic acid levels in smokers","DEFB132":"colorectal or endometrial cancer","DEFB132":"red blood cell count","DNMT3B":"attention deficit hyperactivity disorder (combined symptoms)","DNMT3B":"inflammatory bowel disease","DNMT3B":"lymphocyte counts","DNMT3B":"lymphocyte percentage of white cells","DTD1":"obesity-related traits","DTD1":"night sleep phenotypes","E2F1":"asthma","EFCAB8":"attention deficit hyperactivity disorder (combined symptoms)","EFCAB8":"type 1 diabetes nephropathy","EPB41L1":"height","EPB41L1":"hip circumference","ESF1":"intelligence (childhood)","EYA2":"creutzfeldt-jakob disease","EYA2":"creutzfeldt-jakob disease (variant)","EYA2":"prion diseases","EYA2":"thiazide-induced adverse metabolic effects in hypertensive patients","EYA2":"waist-to-hip ratio adjusted for body mass index","EYA2":"creutzfeldt-jakob disease (sporadic)","EYA2":"facial morphology (factor 19)","EYA2":"waist-to-hip ratio adjusted for bmi in active individuals","EYA2":"waist-to-hip ratio adjusted for bmi (joint analysis main effects and smoking interaction)","EYA2":"waist-to-hip ratio adjusted for bmi (joint analysis for main effect and physical activity interaction)","EYA2":"waist-to-hip ratio adjusted for bmi (adjusted for smoking behaviour)","EYA2":"type 2 diabetes","EYA2":"brain volume in infants (intracranial brain volume)","FAM110A":"obesity-related traits","FAM110A":"response to paliperidone in schizophrenia (multivariate)","FAM209B":"obesity-related traits","FERMT1":"metabolite levels  (x-11787)","FERMT1":"survival in colon cancer","FERMT1":"inflammatory bowel disease","FERMT1":"crohn's disease","FERMT1":"monocyte chemoattractant protein-3 levels","FKBP1A":"intelligence (childhood)","GDF5":"height","GDF5":"infant length","GDF5":"waist-to-hip ratio adjusted for body mass index","GDF5":"joint mobility (beighton score)","GDF5":"hip circumference adjusted for bmi","GDF5":"hip circumference","GDF5":"waist-to-hip ratio adjusted for bmi in active individuals","GDF5":"waist-to-hip ratio adjusted for bmi (joint analysis for main effect and physical activity interaction)","GGT7":"coronary artery disease","GGT7":"neuroticism","GNAS":"event-related brain oscillations","GNAS":"renal function-related traits (bun)","GNAS":"waist circumference adjusted for body mass index","GNAS":"post bronchodilator fev1/fvc ratio","GNAS":"sulfasalazine-induced agranulocytosis","GNAS":"platelet distribution width","GPCPD1":"occipital cortical area (total cortical area interaction)","GPCPD1":"migraine without aura","GPCPD1":"3-hydroxypropylmercapturic acid levels in smokers","GPCPD1":"motion sickness","GPCPD1":"body mass index","GPCPD1":"initial pursuit acceleration","HNF4A":"hdl cholesterol","HNF4A":"type 2 diabetes","HNF4A":"cholesterol, total","HNF4A":"c-reactive protein levels","HNF4A":"c-reactive protein","HNF4A":"fibrinogen levels","HNF4A":"gut microbiota (bacterial taxa)","HNF4A":"c-reactive protein levels or total cholesterol levels (pleiotropy)","HNF4A":"c-reactive protein levels or ldl-cholesterol levels (pleiotropy)","HNF4A":"c-reactive protein levels or hdl-cholesterol levels (pleiotropy)","HNF4A":"neutrophil percentage of white cells","HNF4A":"myeloid white cell count","HNF4A":"sum neutrophil eosinophil counts","HNF4A":"sum basophil neutrophil counts","HNF4A":"granulocyte count","HNF4A":"hematocrit","HNF4A":"neutrophil count","ISM1":"metabolite levels  (x-11787)","ISM1":"survival in colon cancer","ISM1":"night sleep phenotypes","ITPA":"ribavirin-induced anemia","ITPA":"chronic hepatitis c infection","ITPA":"inflammatory bowel disease","ITPA":"chronic obstructive pulmonary disease","KCNB1":"qt interval","KCNB1":"obesity-related traits","KCNB1":"schizophrenia","KCNB1":"white matter hyperintensity burden","KCNB1":"alanine aminotransferase (alt) levels after remission induction therapy in actute lymphoblastic leukemia (all)","KCNB1":"colonoscopy-negative controls vs population controls","KCNB1":"intelligence (multi-trait analysis)","KCNS1":"bipolar disorder","KCNS1":"mean platelet volume","KIAA1755":"heart rate","KIAA1755":"resting heart rate","KIAA1755":"photic sneeze reflex","KIAA1755":"heart rate variability traits (sdnn)","KIAA1755":"heart rate variability traits (rmssd)","KIF16B":"type 1 diabetes","KIF16B":"ileal carcinoids","KIF16B":"response to taxane treatment (docetaxel)","KIF16B":"emphysema imaging phenotypes","KIF16B":"asthma","KIF16B":"post bronchodilator fev1/fvc ratio","KIZ":"lupus nephritis in systemic lupus erythematosus","KIZ":"height","KIZ":"peanut allergy","LAMA5":"colorectal cancer","LAMA5":"3-hydroxy-1-methylpropylmercapturic acid levels in smokers","LAMA5":"pelvic organ prolapse","LZTS3":"subcortical brain region volumes","LZTS3":"oppositional defiant disorder dimensions in attention-deficit hyperactivity disorder","LZTS3":"plateletcrit","LZTS3":"platelet count","LZTS3":"putamen volume","MACROD2":"obesity (extreme)","MACROD2":"mean platelet volume","MACROD2":"autism","MACROD2":"non-alcoholic fatty liver disease histology (other)","MACROD2":"eating disorders","MACROD2":"circulating myeloperoxidase levels (serum)","MACROD2":"amyotrophic lateral sclerosis (sporadic)","MACROD2":"obesity-related traits","MACROD2":"presence of antiphospholipid antibodies","MACROD2":"male fertility","MACROD2":"white matter lesion progression","MACROD2":"mood disorder in prion disease","MACROD2":"3-hydroxy-1-methylpropylmercapturic acid levels in smokers","MACROD2":"thyroid-associated orbitopathy in graves' disease","MACROD2":"percentage gas trapping","MACROD2":"body mass index","MACROD2":"advanced glycation end-product levels","MACROD2":"coronary artery aneurysm in kawasaki disease","MACROD2":"facial morphology (factor 10, width of nasal floor)","MACROD2":"pediatric bone mineral content (hip)","MACROD2":"pediatric bone mineral density (hip)","MACROD2":"trail levels","MACROD2":"pediatric bone mineral density (femoral neck)","MACROD2":"peripheral arterial disease (traffic-related air pollution interaction)","MACROD2":"interleukin-10 levels","MACROD2":"interleukin-12p70 levels","MACROD2":"epstein-barr virus copy number in lymphoblastoid cell lines","MACROD2":"platelet distribution width","MACROD2":"plateletcrit","MACROD2":"common carotid intima-media thickness in hiv infection","MACROD2":"intelligence (multi-trait analysis)","MAPRE1":"attention deficit hyperactivity disorder (combined symptoms)","MAPRE1":"attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms)","MAPRE1":"iron status biomarkers (transferrin saturation)","MAVS":"circulating leptin levels","MAVS":"circulating leptin levels adjusted for bmi","MAVS":"schizophrenia","MAVS":"modified stumvoll insulin sensitivity index (bmi interaction)","MAVS":"liver fibrosis in pediatric non-alcoholic fatty acid liver disease","MCM8":"menarche and menopause (age at onset)","MCM8":"menopause (age at onset)","MCM8":"response to tocilizumab in rheumatoid arthritis","MCM8":"preeclampsia","MCM8":"hiv-1 viral setpoint","MCM8":"schizophrenia","MCM8":"breast cancer","MCM8":"intelligence (multi-trait analysis)","MMP24":"attention deficit hyperactivity disorder","MMP24OS":"attention deficit hyperactivity disorder","MMP24OS":"ulcerative colitis","MRGBP":"subjective well-being","MYBL2":"autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)","MYH7B":"anticoagulant levels","MYH7B":"congenital left-sided heart lesions","MYH7B":"melanoma","MYT1":"colorectal cancer","MYT1":"restless legs syndrome","NAPB":"facial morphology (factor 15, philtrum width)","NCOA3":"response to treatment for acute lymphoblastic leukemia","NCOA3":"systemic lupus erythematosus","NCOA6":"glomerular filtration rate (creatinine)","NCOA6":"diisocyanate-induced asthma","NCOA6":"hip circumference adjusted for bmi","NCOA6":"coronary artery disease","NFATC2":"self-reported allergy","NFATC2":"amyotrophic lateral sclerosis (sporadic)","NFATC2":"sitting height ratio","NFATC2":"asparaginase hypersensitivity in acute lymphoblastic leukemia","NFATC2":"eosinophil percentage of white cells","NFATC2":"sum eosinophil basophil counts","NFATC2":"allergic disease (asthma, hay fever or eczema)","NFATC2":"lobe attachment (rater-scored or self-reported)","NFATC2":"white matter microstructure in first episode schizophrenia (right anterior cingulate cortex)","NFS1":"response to paliperidone in schizophrenia (panss score)","NFS1":"response to paliperidone in schizophrenia (multivariate)","NOL4L":"age at first birth","NOL4L":"chronic obstructive pulmonary disease","NOL4L":"monocyte count","NOL4L":"immature fraction of reticulocytes","NOL4L":"mean corpuscular hemoglobin","NOL4L":"red blood cell count","NOL4L":"red cell distribution width","NOL4L":"high light scatter reticulocyte count","NOL4L":"high light scatter reticulocyte percentage of red cells","NOL4L":"mean corpuscular volume","NPBWR2":"body mass index","NRSN2":"height","NRSN2":"attention deficit hyperactivity disorder","NRSN2":"freckling","NRSN2":"protein c levels","NRSN2":"cholesterol, total","NRSN2":"d-dimer levels","NRSN2":"anticoagulant levels","NRSN2":"hemostatic factors and hematological phenotypes","NRSN2":"prothrombin time","NRSN2":"ulcerative colitis","NRSN2":"spine bone size","NRSN2":"migraine - clinic-based","NRSN2":"amyotrophic lateral sclerosis (sporadic)","NRSN2":"infant length","NRSN2":"waist-to-hip ratio adjusted for body mass index","NRSN2":"developmental dysplasia of the hip","NRSN2":"venous thromboembolism","NRSN2":"factor vii levels","NRSN2":"glomerular filtration rate (creatinine)","NRSN2":"triglycerides","NRSN2":"thrombosis","NRSN2":"qrs complex (cornell)","NRSN2":"congenital left-sided heart lesions","NRSN2":"melanoma","NRSN2":"diisocyanate-induced asthma","NRSN2":"response to paliperidone in schizophrenia (panss score)","NRSN2":"response to paliperidone in schizophrenia (multivariate)","NRSN2":"joint mobility (beighton score)","NRSN2":"hip circumference adjusted for bmi","NRSN2":"qrs interval (sulfonylurea treatment interaction)","NRSN2":"hip circumference","NRSN2":"total cholesterol levels","NRSN2":"waist-to-hip ratio adjusted for bmi in active individuals","NRSN2":"blood protein levels","NRSN2":"waist-to-hip ratio adjusted for bmi (joint analysis for main effect and physical activity interaction)","NRSN2":"breast cancer","NRSN2":"coronary artery disease","NRSN2":"lobe attachment (rater-scored or self-reported)","NRSN2":"neuroticism","NSFL1C":"intelligence (multi-trait analysis)","PAK5":"obesity-related traits","PAK5":"psoriasis","PAK5":"3-hydroxypropylmercapturic acid levels in smokers","PAK5":"growth-regulated protein alpha levels","PANK2":"dialysis-related mortality","PANK2":"alcohol and nicotine co-dependence","PANK2":"response to amphetamines","PANK2":"post bronchodilator fev1/fvc ratio","PANK2":"huntington's disease progression","PANK2":"alcohol dependence or chronic alcoholic pancreatitis or alcohol-related liver cirrhosis","PANK2":"colonoscopy-negative controls vs population controls","PANK2":"intraocular pressure","PANK2":"itch intensity from mosquito bite adjusted by bite size","PANK2":"measles","PCSK2":"biochemical measures","PCSK2":"dialysis-related mortality","PCSK2":"preschool internalizing problems","PCSK2":"obesity-related traits","PCSK2":"gut microbiome composition (summer)","PCSK2":"interleukin-1-beta levels","PDYN":"bipolar disorder (body mass index interaction)","PDYN":"bipolar disorder and schizophrenia","PDYN":"obesity-related traits","PDYN":"verbal declarative memory","PDYN":"platelet distribution width","PFDN4":"obesity-related traits","PHACTR3":"menarche and menopause (age at onset)","PHACTR3":"menopause (age at onset)","PHACTR3":"response to tocilizumab in rheumatoid arthritis","PHACTR3":"preeclampsia","PHACTR3":"hiv-1 viral setpoint","PHACTR3":"schizophrenia","PHACTR3":"breast cancer","PHACTR3":"intelligence (multi-trait analysis)","PHF20":"migraine - clinic-based","PHF20":"height","PHF20":"response to paliperidone in schizophrenia (panss score)","PHF20":"response to paliperidone in schizophrenia (multivariate)","PHF20":"breast cancer","PLCB1":"response to irinotecan in non-small-cell lung cancer","PLCB1":"social communication problems","PLCB1":"cognitive performance","PLCB1":"obesity-related traits","PLCB1":"estradiol plasma levels (breast cancer)","PLCB1":"suicide ideation score in major depressive disorder","PLCB1":"chronic kidney disease","PLCB1":"3-hydroxypropylmercapturic acid levels in smokers","PLCB1":"3-hydroxy-1-methylpropylmercapturic acid levels in smokers","PLCB1":"daytime sleep phenotypes","PLCB1":"obstructive sleep apnea trait (average respiratory event duration)","PLCB1":"response to paliperidone in schizophrenia (multivariate)","PLCB1":"diastolic blood pressure","PLCB1":"monocyte count","PLCB1":"lymphocyte counts","PLCB1":"platelet distribution width","PLCB1":"white blood cell count","PLCB1":"plateletcrit","PLCB1":"platelet count","PLCG1":"cholesterol, total","PLCG1":"height","PLCG1":"age-related disease endophenotypes","PLCG1":"age-related diseases, mortality and associated endophenotypes","PLCG1":"hemoglobin concentration","PLCG1":"coronary artery disease","PMEPA1":"warfarin maintenance dose","PMEPA1":"verbal declarative memory","POFUT1":"chronic obstructive pulmonary disease","PPP1R16B":"schizophrenia","PPP1R16B":"alcohol dependence or chronic alcoholic pancreatitis or alcohol-related liver cirrhosis","PREX1":"tonometry","PREX1":"narcolepsy with cataplexy","PREX1":"colorectal cancer","PREX1":"multiple myeloma","PREX1":"diastolic blood pressure","PREX1":"intelligence (multi-trait analysis)","PRNP":"creutzfeldt-jakob disease","PRNP":"creutzfeldt-jakob disease (variant)","PRNP":"prion diseases","PRNP":"visceral adipose tissue/subcutaneous adipose tissue ratio","PRNP":"waist-to-hip ratio adjusted for body mass index","PRNP":"creutzfeldt-jakob disease (sporadic)","PRNP":"post bronchodilator fev1/fvc ratio","PRNP":"waist-to-hip ratio adjusted for bmi in active individuals","PRNP":"waist-to-hip ratio adjusted for bmi (joint analysis main effects and smoking interaction)","PRNP":"waist-to-hip ratio adjusted for bmi (joint analysis for main effect and physical activity interaction)","PRNP":"waist-to-hip ratio adjusted for bmi (adjusted for smoking behaviour)","PROCR":"protein c levels","PROCR":"d-dimer levels","PROCR":"anticoagulant levels","PROCR":"hemostatic factors and hematological phenotypes","PROCR":"ulcerative colitis","PROCR":"amyotrophic lateral sclerosis (sporadic)","PROCR":"height","PROCR":"venous thromboembolism","PROCR":"factor vii levels","PROCR":"thrombosis","PROCR":"blood protein levels","PROCR":"coronary artery disease","PRPF6":"colorectal cancer","PSMF1":"cardiac hypertrophy","PSMF1":"response to citalopram treatment","PSMF1":"relative hand skill","PSMF1":"gut microbiome composition (summer)","PSMF1":"night sleep phenotypes","PSMF1":"angiotensin-converting enzyme inhibitor intolerance","PSMF1":"breast cancer","PSMF1":"coronary artery calcified atherosclerotic plaque (130 hu threshold) in type 2 diabetes","PTGIS":"schizophrenia","PTK6":"hair shape","PTPN1":"hair morphology","PTPRT":"periodontitis (mean pal)","PTPRT":"preeclampsia","PTPRT":"fractional exhaled nitric oxide (childhood)","PTPRT":"igg glycosylation","PTPRT":"age-related nuclear cataracts","PTPRT":"urate levels in obese individuals","PTPRT":"sense of smell","PTPRT":"microalbuminuria","PTPRT":"facial morphology (factor 20)","PTPRT":"diisocyanate-induced asthma","PTPRT":"response to paliperidone in schizophrenia (negative marder score)","PTPRT":"venous thromboembolism adjusted for sickle cell variant rs77121243-t","PTPRT":"paneth cell defects in crohn's disease","PTPRT":"problematic alcohol use in trauma-exposed individuals","PTPRT":"mononucleosis","PXMP4":"height","PXMP4":"post bronchodilator fev1/fvc ratio","RAB22A":"change in lvef in response to paclitaxel and trastuzumab in her2+ breast cancer","RAD21L1":"brain structure","RAD21L1":"response to cytadine analogues (cytosine arabinoside)","RAD21L1":"neuroticism","RAD21L1":"vascular brain injury","RAD21L1":"cognitive decline rate in late mild cognitive impairment","RAD21L1":"night sleep phenotypes","RAD21L1":"tumor necrosis factor alpha levels","RAD21L1":"body mass index (recreational physical activity interaction)","RAD21L1":"itch intensity from mosquito bite adjusted by bite size","RALY":"ifn-related cytopenia","RALY":"breast cancer","RALY":"facial pigmentation","RALY":"squamous cell carcinoma","RALY":"cutaneous squamous cell carcinoma","RALY":"skin sensitivity to sun","RALY":"skin colour saturation","RALY":"basal cell carcinoma","RALY":"cancer","RALY":"cancer (pleiotropy)","RALY":"melanoma","RALY":"vitiligo","RBBP8NL":"coronary artery calcified atherosclerotic plaque (130 hu threshold) in type 2 diabetes","RBCK1":"panic disorder","RBCK1":"ldl cholesterol","RBCK1":"cholesterol, total","RBCK1":"hippocampal atrophy","RBCK1":"periodontitis (mean pal)","RBCK1":"preeclampsia","RBCK1":"fractional exhaled nitric oxide (childhood)","RBCK1":"height","RBCK1":"igg glycosylation","RBCK1":"metabolite levels (hva-5-hiaa factor score)","RBCK1":"age-related nuclear cataracts","RBCK1":"urate levels in obese individuals","RBCK1":"gastric adenocarcinoma (histologically verified)","RBCK1":"3-hydroxypropylmercapturic acid levels in smokers","RBCK1":"bone mineral accretion in asthma (oral corticosteroid dose interaction)","RBCK1":"dementia and core alzheimer's disease neuropathologic changes","RBCK1":"verbal declarative memory","RBCK1":"sense of smell","RBCK1":"resting heart rate","RBCK1":"non-response to bupropion and depression","RBCK1":"microalbuminuria","RBCK1":"facial morphology (factor 20)","RBCK1":"accelerated cognitive decline after conversion of mild cognitive impairment to alzheimer's disease (alzhiemer's diagnosis trajectory interaction)","RBCK1":"diisocyanate-induced asthma","RBCK1":"age-related disease endophenotypes","RBCK1":"response to paliperidone in schizophrenia (negative marder score)","RBCK1":"age-related diseases, mortality and associated endophenotypes","RBCK1":"venous thromboembolism adjusted for sickle cell variant rs77121243-t","RBCK1":"ldl cholesterol levels","RBCK1":"paneth cell defects in crohn's disease","RBCK1":"total cholesterol levels","RBCK1":"interleukin-18 levels","RBCK1":"qt interval (ambient particulate matter interaction)","RBCK1":"immature fraction of reticulocytes","RBCK1":"hemoglobin concentration","RBCK1":"left ventricle wall thickness","RBCK1":"reticulocyte fraction of red cells","RBCK1":"high light scatter reticulocyte count","RBCK1":"high light scatter reticulocyte percentage of red cells","RBCK1":"reticulocyte count","RBCK1":"coronary artery disease","RBCK1":"hepatitis b","RBCK1":"mononucleosis","RBL1":"height","RNF24":"cytomegalovirus antibody response","RNF24":"telomere length","RNF24":"estradiol levels","RNF24":"response to serotonin reuptake inhibitors in major depressive disorder (plasma drug and metabolite levels)","RNF24":"obesity-related traits","RNF24":"schizophrenia","RNF24":"height","RNF24":"cognitive decline rate in late mild cognitive impairment","RNF24":"chin dimples","RNF24":"response to antidepressants in depression","RNF24":"nevirapine-induced hypersensitivity in hiv (drug-induced liver injury)","RNF24":"nose size","RNF24":"platelet-derived growth factor bb levels","RNF24":"cleft lip with or without cleft palate","RNF24":"interleukin-4 levels","RNF24":"interleukin-17 levels","RNF24":"immature fraction of reticulocytes","RNF24":"monocyte percentage of white cells","RNF24":"multiple myeloma","RNF24":"granulocyte percentage of myeloid white cells","RNF24":"reticulocyte fraction of red cells","RNF24":"high light scatter reticulocyte count","RNF24":"high light scatter reticulocyte percentage of red cells","RNF24":"mean corpuscular volume","RNF24":"reticulocyte count","RNF24":"intraocular pressure","RNF24":"idiopathic osteonecrosis of the femoral head","RNF24":"dupuytren's disease","RRBP1":"coronary artery disease","RTEL1":"glioma","RTEL1":"glioma (high-grade)","RTEL1":"ulcerative colitis","RTEL1":"dental caries","RTEL1":"glioblastoma","RTEL1":"atopic dermatitis","RTEL1":"non-glioblastoma glioma","RTEL1":"plateletcrit","RTEL1":"telomere length","RTEL1":"allergic disease (asthma, hay fever or eczema)","SCAND1":"hip circumference adjusted for bmi","SCRT2":"body mass index","SCRT2":"colorectal cancer","SCRT2":"height","SCRT2":"waist-to-hip ratio adjusted for body mass index","SCRT2":"sitting height ratio","SCRT2":"lung function (fvc)","SCRT2":"waist circumference adjusted for body mass index","SCRT2":"waist circumference adjusted for bmi in active individuals","SCRT2":"waist circumference adjusted for bmi (joint analysis main effects and physical activity interaction)","SCRT2":"waist circumference adjusted for bmi (adjusted for smoking behaviour)","SCRT2":"waist circumference adjusted for bmi (joint analysis main effects and smoking interaction)","SCRT2":"waist circumference adjusted for bmi in non-smokers","SCRT2":"waist-to-hip ratio adjusted for bmi (joint analysis for main effect and physical activity interaction)","SCRT2":"waist-to-hip ratio adjusted for bmi (adjusted for smoking behaviour)","SDCBP2":"personality traits in bipolar disorder","SDCBP2":"metabolite levels  (x-11787)","SDCBP2":"survival in colon cancer","SDCBP2":"night sleep phenotypes","SDCBP2":"body mass index (alcohol intake interaction)","SIGLEC1":"height","SIGLEC1":"red cell distribution width","SIRPA":"pulmonary function decline","SIRPA":"psychosis (atypical)","SIRPA":"response to citalopram or escitalopram and depression","SIRPA":"qt interval (sulfonylurea treatment interaction)","SIRPA":"daytime sleepiness","SIRPA":"basophil percentage of granulocytes","SIRPA":"mean platelet volume","SIRPA":"alcoholic chronic pancreatitis","SIRPB1":"brain connectivity","SIRPB1":"presence of antiphospholipid antibodies","SIRPB1":"thyroid-associated orbitopathy in graves' disease","SIRPB1":"yu-zhi constitution type in type 2 diabetes","SIRPB1":"body mass index","SIRPB1":"trail levels","SIRPB1":"epstein-barr virus copy number in lymphoblastoid cell lines","SIRPB1":"endometriosis","SIRPB2":"autism","SIRPB2":"circulating myeloperoxidase levels (serum)","SIRPB2":"presence of antiphospholipid antibodies","SIRPB2":"intelligence (multi-trait analysis)","SIRPD":"obesity (extreme)","SIRPD":"male fertility","SIRPD":"coronary artery aneurysm in kawasaki disease","SIRPD":"platelet distribution width","SIRPD":"mean platelet volume","SIRPD":"plateletcrit","SIRPG":"type 1 diabetes","SIRPG":"ileal carcinoids","SIRPG":"response to taxane treatment (docetaxel)","SIRPG":"emphysema imaging phenotypes","SIRPG":"post bronchodilator fev1/fvc ratio","SLC13A3":"chronic kidney disease","SLC13A3":"glomerular filtration rate","SLC13A3":"gout","SLC13A3":"brain volume in infants (white matter)","SLC23A2":"tonometry","SLC23A2":"psoriasis","SLC23A2":"narcolepsy with cataplexy","SLC23A2":"qt interval","SLC23A2":"anger","SLC23A2":"systemic lupus erythematosus","SLC23A2":"height","SLC23A2":"obesity-related traits","SLC23A2":"schizophrenia","SLC23A2":"infant length","SLC23A2":"palmitic acid (16:0) levels","SLC23A2":"urate levels in obese individuals","SLC23A2":"white matter hyperintensity burden","SLC23A2":"inflammatory skin disease","SLC23A2":"colorectal cancer","SLC23A2":"psoriasis vulgaris","SLC23A2":"gut microbiota (beta diversity)","SLC23A2":"educational attainment (years of education)","SLC23A2":"non-response to citalopram or escitalopram and depression","SLC23A2":"subjective well-being","SLC23A2":"life satisfaction","SLC23A2":"positive affect","SLC23A2":"depression","SLC23A2":"intelligence","SLC23A2":"alanine aminotransferase (alt) levels after remission induction therapy in actute lymphoblastic leukemia (all)","SLC23A2":"multiple myeloma","SLC23A2":"diastolic blood pressure","SLC23A2":"waist circumference adjusted for bmi (joint analysis main effects and smoking interaction)","SLC23A2":"waist circumference adjusted for bmi in non-smokers","SLC23A2":"waist circumference adjusted for bmi (adjusted for smoking behaviour)","SLC23A2":"coronary artery disease","SLC23A2":"colonoscopy-negative controls vs population controls","SLC23A2":"cognitive ability","SLC23A2":"cognitive ability (multi-trait analysis)","SLC23A2":"hepatitis b","SLC23A2":"intelligence (multi-trait analysis)","SLC24A3":"mean platelet volume","SLC24A3":"aortic root size","SLC24A3":"pulmonary function decline","SLC24A3":"psychosis (atypical)","SLC24A3":"liver enzyme levels (alanine transaminase)","SLC24A3":"matrix metalloproteinase levels","SLC24A3":"age at smoking initiation in chronic obstructive pulmonary disease","SLC24A3":"migraine","SLC24A3":"peripheral arterial disease (traffic-related air pollution interaction)","SLC24A3":"qt interval (sulfonylurea treatment interaction)","SLC24A3":"pulse pressure","SLC24A3":"white blood cell count (basophil)","SLC24A3":"neutrophil percentage of white cells","SLC24A3":"daytime sleepiness","SLC24A3":"lymphocyte counts","SLC24A3":"lymphocyte percentage of white cells","SLC24A3":"basophil percentage of granulocytes","SLC24A3":"platelet distribution width","SLC24A3":"plateletcrit","SLC24A3":"platelet count","SLX4IP":"body mass index (change over time) in chronic obstructive pulmonary disease","SLX4IP":"fasting blood glucose adjusted for bmi","SMOX":"hippocampal atrophy","SMOX":"height","SMOX":"gastric adenocarcinoma (histologically verified)","SMOX":"bone mineral accretion in asthma (oral corticosteroid dose interaction)","SMOX":"dementia and core alzheimer's disease neuropathologic changes","SMOX":"verbal declarative memory","SMOX":"age-related disease endophenotypes","SMOX":"age-related diseases, mortality and associated endophenotypes","SMOX":"immature fraction of reticulocytes","SMOX":"left ventricle wall thickness","SMOX":"reticulocyte fraction of red cells","SMOX":"high light scatter reticulocyte count","SMOX":"high light scatter reticulocyte percentage of red cells","SMOX":"reticulocyte count","SMOX":"coronary artery disease","SMOX":"hepatitis b","SNAP25":"educational attainment","SNAP25":"diisocyanate-induced asthma","SNAP25":"mononucleosis","SNPH":"sphingolipid levels","SNPH":"ldl cholesterol","SNPH":"brain structure","SNPH":"blood metabolite levels","SNPH":"blood metabolite ratios","SNPH":"very long-chain saturated fatty acid levels (fatty acid 20:0)","SNPH":"glycerophospholipid levels","SNPH":"neuroticism","SNPH":"very long-chain saturated fatty acid levels (fatty acid 24:0)","SNPH":"parental extreme longevity (95 years and older)","SNPH":"daytime sleep phenotypes","SNPH":"ldl cholesterol levels","SNPH":"body mass index (recreational physical activity interaction)","SOX12":"attention deficit hyperactivity disorder (combined symptoms)","SOX12":"attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms)","SOX12":"type 1 diabetes nephropathy","SOX12":"inflammatory bowel disease","SOX12":"type 2 diabetes","SOX12":"ulcerative colitis","SOX12":"subjective well-being","SOX12":"iron status biomarkers (iron levels)","SOX12":"iron status biomarkers (transferrin saturation)","SOX12":"monocyte count","SOX12":"white blood cell count (basophil)","SOX12":"basophil percentage of white cells","SOX12":"lymphocyte counts","SOX12":"lymphocyte percentage of white cells","SOX12":"monocyte percentage of white cells","SOX12":"basophil percentage of granulocytes","SOX12":"granulocyte percentage of myeloid white cells","SOX12":"red cell distribution width","SOX12":"birth weight","SPTLC3":"personality traits in bipolar disorder","SPTLC3":"daytime sleep phenotypes","SPTLC3":"body mass index (alcohol intake interaction)","SRXN1":"height","SRXN1":"qrs complex (cornell)","SRXN1":"hip circumference adjusted for bmi","STAU1":"height","STAU1":"cognitive ability","STAU1":"cognitive ability (multi-trait analysis)","STAU1":"intelligence (multi-trait analysis)","STK4":"schizophrenia","STK4":"positive affect","STK35":"lupus nephritis in systemic lupus erythematosus","STK35":"hirschsprung disease","STK35":"body mass index","STK35":"height","STK35":"cannabis dependence symptom count","STK35":"nose morphology","STK35":"facial morphology (factor 7, width of cartilaginous portion of nose)","STK35":"pediatric bone mineral content (radius)","STK35":"sulfasalazine-induced agranulocytosis","STK35":"mean corpuscular hemoglobin","STK35":"peanut allergy","SULF2":"attention deficit hyperactivity disorder (time to onset)","SULF2":"post bronchodilator fev1/fvc ratio in copd","TAF4":"smooth-surface caries","TAF4":"body mass index","TBC1D20":"rheumatoid arthritis","TBC1D20":"hdl cholesterol","TBC1D20":"triglycerides","TBC1D20":"multiple sclerosis","TBC1D20":"psoriasis","TBC1D20":"type 2 diabetes","TBC1D20":"cholesterol, total","TBC1D20":"ulcerative colitis","TBC1D20":"c-reactive protein levels","TBC1D20":"lipid metabolism phenotypes","TBC1D20":"kawasaki disease","TBC1D20":"metabolite levels","TBC1D20":"bipolar disorder","TBC1D20":"brain structure","TBC1D20":"conduct disorder (symptom count)","TBC1D20":"response to amphetamines","TBC1D20":"c-reactive protein","TBC1D20":"cognitive performance","TBC1D20":"autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)","TBC1D20":"igg glycosylation","TBC1D20":"obesity-related traits","TBC1D20":"current cigarettes per day in chronic obstructive pulmonary disease","TBC1D20":"clozapine-induced agranulocytosis","TBC1D20":"inflammatory bowel disease","TBC1D20":"chronic hepatitis b infection","TBC1D20":"hemoglobin levels","TBC1D20":"crohn's disease","TBC1D20":"3-hydroxypropylmercapturic acid levels in smokers","TBC1D20":"3-hydroxy-1-methylpropylmercapturic acid levels in smokers","TBC1D20":"pathological gambling","TBC1D20":"schizophrenia","TBC1D20":"pancreatic cancer","TBC1D20":"glomerular filtration rate (creatinine)","TBC1D20":"parental longevity (mother's age at death)","TBC1D20":"coenzyme q10 levels","TBC1D20":"fibrinogen levels","TBC1D20":"advanced age-related macular degeneration","TBC1D20":"plasma omega-6 polyunsaturated fatty acid levels (arachidonic acid)","TBC1D20":"mild influenza (h1n1) infection","TBC1D20":"gut microbiota (functional units)","TBC1D20":"gut microbiota (bacterial taxa)","TBC1D20":"abdominal aortic aneurysm","TBC1D20":"tonsillectomy","TBC1D20":"late-onset alzheimer's disease","TBC1D20":"c-reactive protein levels or total cholesterol levels (pleiotropy)","TBC1D20":"c-reactive protein levels or triglyceride levels (pleiotropy)","TBC1D20":"c-reactive protein levels or ldl-cholesterol levels (pleiotropy)","TBC1D20":"c-reactive protein levels or hdl-cholesterol levels (pleiotropy)","TBC1D20":"metabolite levels (lipoprotein measures)","TBC1D20":"positive affect","TBC1D20":"post bronchodilator fev1/fvc ratio in copd","TBC1D20":"post bronchodilator fev1/fvc ratio","TBC1D20":"facial morphology (factor 13, vertical position of alar curvature relative to upper lip)","TBC1D20":"facial morphology (factor 21, depth of nasal alae)","TBC1D20":"hdl cholesterol levels","TBC1D20":"waist circumference adjusted for bmi (smoking interaction)","TBC1D20":"triglyceride levels","TBC1D20":"monocyte count","TBC1D20":"neutrophil percentage of white cells","TBC1D20":"blood protein levels","TBC1D20":"waist circumference adjusted for bmi (joint analysis main effects and smoking interaction)","TBC1D20":"lymphocyte percentage of white cells","TBC1D20":"myeloid white cell count","TBC1D20":"monocyte percentage of white cells","TBC1D20":"sum neutrophil eosinophil counts","TBC1D20":"sum basophil neutrophil counts","TBC1D20":"granulocyte count","TBC1D20":"granulocyte percentage of myeloid white cells","TBC1D20":"hematocrit","TBC1D20":"mean corpuscular hemoglobin","TBC1D20":"red blood cell count","TBC1D20":"mean corpuscular volume","TBC1D20":"mean platelet volume","TBC1D20":"neutrophil count","TBC1D20":"coronary artery disease","TBC1D20":"colonoscopy-negative controls vs population controls","TBC1D20":"asthma","TBC1D20":"bacterial meningitis","TBC1D20":"intelligence (multi-trait analysis)","TCEA2":"serum thyroid-stimulating hormone levels","TCEA2":"diastolic blood pressure","TCF15":"non-alcoholic fatty liver disease histology (other)","TCF15":"menopause (age at onset)","TCF15":"survival in colon cancer","TCF15":"abdominal aortic aneurysm","TCF15":"cough in response to angiotensin-converting enzyme inhibitor drugs","TCFL5":"obesity-related traits","TGM3":"liver enzyme levels (alanine transaminase)","TGM3":"basal cell carcinoma","TGM3":"pr interval in tripanosoma cruzi seropositivity","TGM3":"obesity-related traits","TGM3":"venous thromboembolism","TGM3":"inflammatory skin disease","TGM3":"facial morphology (factor 15, philtrum width)","TGM3":"alanine aminotransferase (alt) levels after remission induction therapy in actute lymphoblastic leukemia (all)","TGM3":"tuberculosis","TGM6":"response to tnf antagonist treatment","TGM6":"erectile dysfunction and prostate cancer treatment","TGM6":"alzheimer's disease (cognitive decline)","TGM6":"3-hydroxypropylmercapturic acid levels in smokers","TGM6":"body mass index (change over time) in cancer or chronic obstructive pulmonary disease","TGM6":"blood protein levels","TM9SF4":"ribavirin-induced anemia","TM9SF4":"chronic hepatitis c infection","TM9SF4":"inflammatory bowel disease","TM9SF4":"chronic obstructive pulmonary disease","TMC2":"systemic lupus erythematosus","TMC2":"obesity-related traits","TMC2":"3-hydroxy-1-methylpropylmercapturic acid levels in smokers","TMC2":"parkinson disease and lewy body pathology","TMC2":"colorectal or endometrial cancer","TMC2":"circulating chromogranin peptide levels","TMC2":"red blood cell count","TMEM230":"bipolar disorder","TMEM230":"molar-incisor hypomineralization","TMEM230":"qt interval (drug interaction)","TMEM230":"prostate cancer","TMEM230":"longitudinal change in brain amyloid plaque burden","TMEM230":"breast cancer","TOX2":"conduct disorder (symptom count)","TOX2":"igg glycosylation","TOX2":"post bronchodilator fev1/fvc ratio in copd","TOX2":"red blood cell count","TRIB3":"bipolar disorder","TRIB3":"bone mineral density","TRIB3":"hippocampal atrophy","TRIB3":"information processing speed","TRIB3":"telomere length","TRIB3":"dialysis-related mortality","TRIB3":"alcohol and nicotine co-dependence","TRIB3":"estradiol levels","TRIB3":"visceral adipose tissue adjusted for bmi","TRIB3":"periodontitis (dpal)","TRIB3":"asthma","TRIB3":"antibody status in tripanosoma cruzi seropositivity","TRIB3":"bipolar disorder and schizophrenia","TRIB3":"response to amphetamines","TRIB3":"igg glycosylation","TRIB3":"retinopathy in non-diabetics","TRIB3":"schizophrenia","TRIB3":"airway wall thickness","TRIB3":"survival in colon cancer","TRIB3":"circulating leptin levels","TRIB3":"circulating leptin levels adjusted for bmi","TRIB3":"heart rate","TRIB3":"height","TRIB3":"post bronchodilator fev1 in copd","TRIB3":"cognitive decline rate in late mild cognitive impairment","TRIB3":"resting heart rate","TRIB3":"chin dimples","TRIB3":"modified stumvoll insulin sensitivity index (bmi interaction)","TRIB3":"squamous cell carcinoma","TRIB3":"post bronchodilator fev1/fvc ratio","TRIB3":"nose size","TRIB3":"photic sneeze reflex","TRIB3":"platelet-derived growth factor bb levels","TRIB3":"hepcidin levels","TRIB3":"cerebrospinal fluid biomarker levels","TRIB3":"skin pigmentation","TRIB3":"interleukin-4 levels","TRIB3":"interleukin-17 levels","TRIB3":"autism spectrum disorder or schizophrenia","TRIB3":"daytime sleepiness","TRIB3":"huntington's disease progression","TRIB3":"alcohol dependence or chronic alcoholic pancreatitis or alcohol-related liver cirrhosis","TRIB3":"reticulocyte fraction of red cells","TRIB3":"red cell distribution width","TRIB3":"high light scatter reticulocyte count","TRIB3":"mean corpuscular volume","TRIB3":"reticulocyte count","TRIB3":"heart rate variability traits (sdnn)","TRIB3":"heart rate variability traits (rmssd)","TRIB3":"triglyceride change in response to fenofibrate in statin-treated type 2 diabetes","TRIB3":"colonoscopy-negative controls vs population controls","TRIB3":"intraocular pressure","TRIB3":"initial pursuit acceleration in psychotic disorders","TRIB3":"itch intensity from mosquito bite adjusted by bite size","TRIB3":"dupuytren's disease","TRIB3":"liver fibrosis in pediatric non-alcoholic fatty acid liver disease","TRIB3":"measles","TSHZ2":"bipolar disorder (body mass index interaction)","TSHZ2":"warfarin maintenance dose","TSHZ2":"coronary artery aneurysm in kawasaki disease","TSHZ2":"urinary tract infection frequency","UBOX5":"red blood cell density in sickle cell anemia","UBOX5":"eosinophil counts","UBOX5":"prudent dietary pattern","UQCC1":"height","UQCC1":"spine bone size","UQCC1":"developmental dysplasia of the hip","UQCC1":"qrs interval (sulfonylurea treatment interaction)","UQCC1":"waist-to-hip ratio adjusted for body mass index","UQCC1":"waist-to-hip ratio adjusted for bmi in active individuals","UQCC1":"waist-to-hip ratio adjusted for bmi (joint analysis for main effect and physical activity interaction)","UQCC1":"blood protein levels","UQCC1":"lobe attachment (rater-scored or self-reported)","ZBTB46":"multiple sclerosis","ZBTB46":"obesity-related traits","ZBTB46":"coronary artery disease","ZFP64":"amyotrophic lateral sclerosis","ZFP64":"facial morphology (factor 23)","ZFP64":"reading disability or specific language impairment (pleiotropy)","ZFP64":"venous thromboembolism adjusted for sickle cell variant rs77121243-t","ZFP64":"testicular germ cell tumor","ZGPAT":"inflammatory bowel disease","ZGPAT":"crohn's disease","ZGPAT":"prostate cancer","ZGPAT":"ulcerative colitis","ZGPAT":"lung function (fev1)","ZHX3":"cholesterol, total","ZHX3":"height","ZHX3":"resting heart rate","ZHX3":"non-response to bupropion and depression","ZHX3":"total cholesterol levels","ZHX3":"left ventricle wall thickness","ZHX3":"coronary artery disease","ZNF133":"body mass index","ZNF217":"mean corpuscular hemoglobin","ZNF217":"red blood cell count","ZNF217":"mean corpuscular volume","ZNF217":"allergic disease (asthma, hay fever or eczema)","ZNF335":"hdl cholesterol","ZNF335":"c-reactive protein levels or triglyceride levels (pleiotropy)","ZNF335":"hdl cholesterol levels","ZNF335":"coronary artery disease","ZNF335":"intelligence (multi-trait analysis)","ZNF341":"height","ZNF343":"allergic rhinitis","ZNF343":"cognitive performance","ZNF343":"glomerular filtration rate in chronic kidney disease","ZNF343":"diisocyanate-induced asthma","ZNF343":"blood protein levels","ZNF343":"conotruncal heart defects (maternal effects)","ZNF831":"hypertension","ZNF831":"blood pressure","ZNF831":"diastolic blood pressure","ZNF831":"systolic blood pressure","ZNF831":"response to antipsychotic therapy (extrapyramidal side effects)","ZNF831":"inflammatory bowel disease","ZNF831":"attention function in attention deficit hyperactive disorder","ZNF831":"ulcerative colitis","ZNF831":"crohn's disease","ZNF831":"lymphocyte counts","ZNF831":"lymphocyte percentage of white cells","ZNF831":"platelet distribution width","ZNF831":"coronary artery disease","ZSWIM3":"3-hydroxypropylmercapturic acid levels in smokers","ZSWIM3":"waist circumference adjusted for bmi (smoking interaction)","ZSWIM3":"waist circumference adjusted for bmi (joint analysis main effects and smoking interaction)"}